CIK: 0001958125 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $476,911 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 53,916 | $42,029 | 8.8% | $796.81 | -2.9% | COM | 532457108 |
| BBIO | BRIDGEBIO PHARMA INC | 927,711 | $40,059 | 8.4% | $26.37 | +37.9% | COM | 10806X102 |
| SLNO | SOLENO THERAPEUTICS INC | 409,944 | $34,345 | 7.2% | $64.58 | +15.9% | COM | 834203309 |
| ASND | ASCENDIS PHARMA A/S | 179,926 | $31,055 | 6.5% | $137.67 | — | SPONSORED ADR | 04351P101 |
| ISRG | INTUITIVE SURGICAL INC | 56,674 | $30,797 | 6.5% | $521.57 | +0.2% | COM NEW | 46120E602 |
| EW | EDWARDS LIFESCIENCES CORP | 390,932 | $30,575 | 6.4% | $70.36 | +6.0% | COM | 28176E108 |
| GILD | GILEAD SCIENCES INC | 226,875 | $25,154 | 5.3% | $104.39 | 0.0% | COM | 375558103 |
| BSX | BOSTON SCIENTIFIC CORP | 229,046 | $24,602 | 5.2% | $101.18 | 0.0% | COM | 101137107 |
| CYTK | CYTOKINETICS INC | 601,439 | $19,872 | 4.2% | $50.21 | -30.7% | COM NEW | 23282W605 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,104,512 | $19,709 | 4.1% | $13.56 | -18.8% | COM | 87164F105 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,170,372 | $19,615 | 4.1% | $16.76 | — | SPONSORED ADS | 881624209 |
| CORT | CORCEPT THERAPEUTICS INC | 239,125 | $17,552 | 3.7% | $72.50 | 0.0% | COM | 218352102 |
| NTRA | NATERA INC | 97,297 | $16,437 | 3.4% | $155.83 | 0.0% | COM | 632307104 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 1,396,445 | $16,269 | 3.4% | $8.47 | +7.2% | COM | 00650F109 |
| DNTH | DIANTHUS THERAPEUTICS INC | 746,527 | $13,908 | 2.9% | $25.71 | -27.0% | COM | 252828108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 670,575 | $13,908 | 2.9% | $25.23 | — | SPONSORED ADS | 86366E106 |
| ADMA | ADMA BIOLOGICS INC | 569,704 | $10,374 | 2.2% | $20.39 | 0.0% | COM | 000899104 |
| HALO | HALOZYME THERAPEUTICS INC | 191,529 | $9,963 | 2.1% | $56.90 | 0.0% | COM | 40637H109 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 213,402 | $7,759 | 1.6% | $36.05 | 0.0% | COM | 90400D108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 162,596 | $7,675 | 1.6% | $42.39 | -3.9% | CLASS A ORD | 61559X104 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 672,290 | $6,447 | 1.4% | $5.53 | 0.0% | COM | 71722W107 |
| QURE | UNIQURE NV | 417,443 | $5,819 | 1.2% | $8.63 | +55.8% | SHS | N90064101 |
| WGS | GENEDX HOLDINGS CORP | 61,507 | $5,678 | 1.2% | $78.50 | 0.0% | COM CL A | 81663L200 |
| TARA | PROTARA THERAPEUTICS INC | 1,626,370 | $4,928 | 1.0% | $3.30 | +4.4% | COM STK | 74365U107 |
| OM | OUTSET MED INC | 166,666 | $3,202 | 0.7% | $11.92 | +30.9% | COM NEW | 690145206 |
| SEPN | SEPTERNA INC | 294,360 | $3,111 | 0.7% | $23.65 | -65.2% | COM | 81734D104 |
| REPL | REPLIMUNE GROUP INC | 330,337 | $3,069 | 0.6% | $12.38 | -29.5% | COM | 76029N106 |
| ZBIO | ZENAS BIOPHARMA INC | 215,314 | $2,086 | 0.4% | $12.75 | -23.6% | COM | 98937L105 |
| VIR | VIR BIOTECHNOLOGY INC | 388,303 | $1,957 | 0.4% | $8.89 | -39.7% | COM | 92764N102 |
| KYTX | KYVERNA THERAPEUTICS INC | 586,909 | $1,802 | 0.4% | $4.79 | -48.4% | COM | 501976104 |
| IRON | DISC MEDICINE INC | 30,661 | $1,624 | 0.3% | $46.97 | 0.0% | COM | 254604101 |
| FULC | FULCRUM THERAPEUTICS INC | 188,304 | $1,296 | 0.3% | $3.67 | +45.6% | COM | 359616109 |
| BCAX | BICARA THERAPEUTICS INC | 97,800 | $909 | 0.2% | $11.92 | 0.0% | COM | 055477103 |
| MGX | METAGENOMI INC | 528,993 | $783 | 0.2% | $2.41 | -35.1% | COM | 59102M104 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 146,013 | $629 | 0.1% | $8.54 | -42.5% | COM NEW | 48576U205 |
| HYPR | HYPERFINE INC | 760,035 | $547 | 0.1% | $0.96 | -27.1% | COM CL A | 44916K106 |
| — | MERSANA THERAPEUTICS INC | 1,567,413 | $464 | 0.1% | $1.43 | — | COM | 59045L106 |
| — | ATAI LIFE SCIENCES NV | 196,858 | $431 | 0.1% | $1.33 | — | SHS | N0731H103 |
| GUTS | FRACTYL HEALTH INC | 214,236 | $347 | 0.1% | $2.33 | -30.6% | COM | 35168W103 |
| SNSE | SENSEI BIOTHERAPEUTICS INC | 14,718 | $126 | 0.0% | $7.18 | 0.0% | COM NEW | 81728A207 |